<--- Back to Details
First PageDocument Content
Malaria / Vaccines / Medicine / Clinical medicine / Health / Malaria vaccine / PfSPZ vaccine / PATH / GlaxoSmithKline / RTS / S
Date: 2015-06-30 11:37:58
Malaria
Vaccines
Medicine
Clinical medicine
Health
Malaria vaccine
PfSPZ vaccine
PATH
GlaxoSmithKline
RTS
S

Hopes rise for malaria vaccine as oil companies fund trials - FT.com, 9:36 AM June 28, :31 am

Add to Reading List

Source URL: www.sanaria.com

Download Document from Source Website

File Size: 219,55 KB

Share Document on Facebook

Similar Documents

Science article: “Protection Against Malaria by Intravenous Immunization with a Non-Replicating Sporozoite Vaccine” What: A phase 1 clinical trial of Sanaria’s malaria vaccine, the Sanaria PfSPZ Vaccine, demonstrat

Science article: “Protection Against Malaria by Intravenous Immunization with a Non-Replicating Sporozoite Vaccine” What: A phase 1 clinical trial of Sanaria’s malaria vaccine, the Sanaria PfSPZ Vaccine, demonstrat

DocID: 1suvJ - View Document

Sanaria® PfSPZ Malaria Vaccine Wins 2014 Vaccine Industry Excellence Award for “Best Prophylactic Vaccine” Rockville, MD - Sanaria received the 2014 Vaccine Industry Excellence Award for the “Best Prophylactic Vac

Sanaria® PfSPZ Malaria Vaccine Wins 2014 Vaccine Industry Excellence Award for “Best Prophylactic Vaccine” Rockville, MD - Sanaria received the 2014 Vaccine Industry Excellence Award for the “Best Prophylactic Vac

DocID: 1rm3H - View Document

Hopes rise for malaria vaccine as oil companies fund trials - FT.com, 9:36 AM June 28, :31 am

Hopes rise for malaria vaccine as oil companies fund trials - FT.com, 9:36 AM June 28, :31 am

DocID: 1qADp - View Document

Investigational Malaria Vaccine Found Safe and Protective  http://www.niaid.nih.gov/news/newsreleases/2013/Pages/PfSPZ... National Institute of Allergy and Infectious Diseases (NIAID)

Investigational Malaria Vaccine Found Safe and Protective http://www.niaid.nih.gov/news/newsreleases/2013/Pages/PfSPZ... National Institute of Allergy and Infectious Diseases (NIAID)

DocID: 1pYml - View Document

GOVERNMENT OF EQUATORIAL GUINEA AND OIL COMPANIES AGREE TO $48.5 MILLION FUNDING OF MALARIA VACCINE DEVELOPMENT PROGRAM WITH SANARIA INC. ROCKVILLE, MD – 29 JuneFor immediate release – The Government of the Re

GOVERNMENT OF EQUATORIAL GUINEA AND OIL COMPANIES AGREE TO $48.5 MILLION FUNDING OF MALARIA VACCINE DEVELOPMENT PROGRAM WITH SANARIA INC. ROCKVILLE, MD – 29 JuneFor immediate release – The Government of the Re

DocID: 1pc1v - View Document